Preprint / Version 1

Government spending on antiretrovirals in Brazil and its main determinants

##article.authors##

DOI:

https://doi.org/10.1590/SciELOPreprints.6303

Keywords:

Anti-Retroviral Agents, HIV, Drug Price, Intellectual Property of Pharmaceutic Products and Process

Abstract

The construction of public policies for the prevention and treatment of HIV/AIDS in Brazil is a history of struggle that unites sanitarians, researchers and activists since the 1980s. An important part of this path is linked to the production and distribution of antiretroviral drugs (ARV), initiatives to reduce the price of ARVs and civil society mobilizations for the guarantee of rights, which contributed to create one of the most successful programs to combat the disease in the country. world. Based on this history, this study aimed to analyze government spending on the acquisition of selected ARVs in the period between 2005 and 2020, making a comparison with international prices, in the light of determinants related to patent disputes, voluntary licensing, PDPs and ARV price reduction initiatives. Among other results, it was possible to observe that there was no immediate relationship between the end of the patent concession and the reduction of prices. Filings of other patent applications and the lack of nationally registered competitors, even after patent expiration, can be significant factors in maintaining high prices.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Author Biographies

Graziela Ferrero Zucoloto, Institute of Applied Economic Research

Pesquisadora do Instituto de Pesquisa Econômica Aplicada (Ipea)

Carolinne Thays Scopel, Associação Interdisciplinar de Aids (Abia)

Associação Brasileira Interdisciplinar de Aids (Abia), consultora farmacêutica do Grupo de Trabalho sobre Propriedade Intelectual da Rede Brasileira pela Integração dos Povos (GTPI/Rebrip).

Pedro Villardi, Associação Brasileira Interdisciplinar de Aids (Abia)

Associação Brasileira Interdisciplinar de Aids (Abia), coordenador do Grupo de Trabalho sobre Propriedade Intelectual da Rede Brasileira pela Integração dos Povos (GTPI/Rebrip).

Felipe de Carvalho Borges da Fonseca, Associação Brasileira Interdisciplinar de Aids (Abia)

Associação Brasileira Interdisciplinar de Aids (Abia), coordenador do Grupo de Trabalho sobre Propriedade Intelectual da Rede Brasileira pela Integração dos Povos (GTPI/Rebrip).

Susana Rodrigues Cavalcanti van der Ploeg, Associação Brasileira Interdisciplinar de Aids (Abia)

Associação Brasileira Interdisciplinar de Aids (Abia), advogada do Grupo de Trabalho sobre Propriedade Intelectual da Rede Brasileira pela Integração dos Povos (GTPI/Rebrip).

Leonardo Szigethy, Institute of Applied Economic Research

Assistente de pesquisa do Instituto de Pesquisa Econômica Aplicada (Ipea)

Posted

07/10/2023

How to Cite

Zucoloto, G. F., Scopel, C. T., Villardi, P., Fonseca, F. de C. B. da, Ploeg, S. R. C. van der, & Szigethy, L. (2023). Government spending on antiretrovirals in Brazil and its main determinants. In SciELO Preprints. https://doi.org/10.1590/SciELOPreprints.6303

Section

Health Sciences

Plaudit

Data statement

  • The research data is contained in the manuscript